Cimzia related Press Releases
Cimzia Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
Cimzia Approved in the US for the Treatment of Moderate to Severe Crohn's Disease Administered every four weeks, UCB's pegylated anti-TNFa offers new treatment option for patients with moderate to... Read more...
PRESS RELEASE: UCB Group Drug Cimzia Faces EU Delay, Shares Plunge
UCB Group Drug Cimzia Faces EU Delay, Shares Plunge Brussels (BELGIUM), November 16, 2007 at 7:00 am CET - UCB announced today that it has been informed by the European Medicines Agency (EMEA) that... Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
